Physician profile
Michael Burke
NPI 1902011588
$6,878.13
in general payments reported to CMS, 2019-2025
24 companies · $2,483 in 2025
The $2,483 reported for 2025 was more than what 77% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,723 · 2020: $191 · 2021: $526 · 2022: $1,434 · 2023: $392 · 2024: $129 · 2025: $2,483.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513 · Travel and Lodging: $1,491.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,512.70 |
| Travel and Lodging | $1,491.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $3,561.13 | 2019-2025 | Indigo System, Penumbra System, Red 72 |
| Relievant Medsystems, INC. | $706.05 | 2022 | |
| Viz.Ai, INC. | $580.13 | 2021-2022 | |
| Inari Medical, INC. | $521.01 | 2020-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $348.99 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $256.11 | 2019-2021 | |
| Boston Scientific Corporation | $180.61 | 2021-2023 | Eluvia |
| Cook Medical LLC | $120.62 | 2019-2023 | Advance |
| Angiodynamics, INC. | $96.78 | 2021-2024 | Soft-Vu |
| Medtronic, INC. | $76.62 | 2021-2022 | |
| Terumo Medical Corporation | $58.06 | 2025 | Azur Cx Detachable |
| Balt USA, LLC | $57.08 | 2022-2023 | Prestige Coil System |
| Biotronik INC. | $46.41 | 2019 | |
| Laborie Medical Technologies Corp. | $32.04 | 2024 | |
| Astrazeneca Pharmaceuticals Lp | $30.24 | 2025 | Imfinzi |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $29.25 | 2023 | Kengreal |
| Janssen Biotech, INC. | $26.48 | 2025 | Erleada, Balversa, Akeega |
| Medtronic Vascular, INC. | $25.75 | 2020 | |
| Genzyme Corporation | $25.13 | 2025 | |
| Ekos Corporation | $24.42 | 2019 | |
| Abbott Laboratories | $24.10 | 2021 | |
| Veryan Medical Incorporated | $18.56 | 2022 | |
| Cardiovascular Systems INC. | $16.74 | 2021 | |
| Bard Peripheral Vascular, INC. | $15.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.